Plasma protein profiling by mass spectrometry for cancer diagnosis: opportunities and limitations.

There is now solid scientific evidence suggesting that early detection of various forms of cancer can lead to improved clinical outcomes [(1)][1]. It has thus been suggested that early cancer diagnosis and administration of definitive therapy is probably the most promising way to reduce the burden

[1]  E. Petricoin,et al.  Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.

[2]  Thomas P Conrads,et al.  SELDI-TOF MS for diagnostic proteomics. , 2003, Analytical chemistry.

[3]  Jeffrey S. Morris,et al.  Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments , 2004, Bioinform..

[4]  T. Yip,et al.  Identification of Serum Amyloid A Protein As a Potentially Useful Biomarker to Monitor Relapse of Nasopharyngeal Cancer by Serum Proteomic Profiling , 2004, Clinical Cancer Research.

[5]  E. Diamandis.  Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? , 2003, Clinical chemistry.

[6]  T. Veenstra,et al.  Characterization of the Low Molecular Weight Human Serum Proteome*S , 2003, Molecular & Cellular Proteomics.

[7]  R. Bast,et al.  Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer , 2004, Cancer Research.

[8]  M. Ferrari,et al.  Clinical proteomics: Written in blood , 2003, Nature.

[9]  Ruth Etzioni,et al.  Early detection: The case for early detection , 2003, Nature Reviews Cancer.

[10]  D. Lockhart,et al.  Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  D. Katsaros,et al.  Parallel overexpression of seven kallikrein genes in ovarian cancer. , 2003, Cancer research.

[12]  A. Stieg,et al.  Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancer. , 2003, Urology.

[13]  E. Diamandis.  Identification of Serum Amyloid A Protein As a Potentially Useful Biomarker for Nasopharyngeal Carcinoma , 2004, Clinical Cancer Research.

[14]  Kevin R Coombes,et al.  Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  David F Ransohoff,et al.  Evaluating discovery-based research: when biologic reasoning cannot work. , 2004, Gastroenterology.

[16]  E. Diamandis.  Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool , 2004, Molecular & Cellular Proteomics.

[17]  Min Zhan,et al.  A data review and re-assessment of ovarian cancer serum proteomic profiling , 2003, BMC Bioinformatics.

[18]  S. Gygi,et al.  Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[19]  R. Aebersold,et al.  Mass spectrometry-based proteomics , 2003, Nature.

[20]  Erika Check,et al.  Proteomics and cancer: Running before we can walk? , 2004, Nature.

[21]  C. Burtis.  Tietz textbook of Clinical Chemistry , 1994 .

[22]  P. Selby,et al.  Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. , 2003, Cancer research.

[23]  E. Diamandis.  Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. , 2004, Journal of the National Cancer Institute.

[24]  D. Oram,et al.  Screening for ovarian cancer. , 2007, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  J. Welsh,et al.  Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  E. Holland,et al.  Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. , 2004, Analytical chemistry.

[27]  Max Marquis,et al.  Written in Blood , 1995 .